Thermo Fisher Scientific Inc (NYSE:TMO) Stake Maintained by Spirit of America Management Corp NY

Spirit of America Management Corp NY maintained its stake in Thermo Fisher Scientific Inc (NYSE:TMO) during the second quarter, according to its most recent disclosure with the SEC. The firm owned 2,700 shares of the medical research company’s stock at the end of the second quarter. Spirit of America Management Corp NY’s holdings in Thermo Fisher Scientific were worth $471,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of TMO. Proficio Capital Partners LLC boosted its stake in Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after buying an additional 253 shares during the period. Independent Portfolio Consultants Inc. boosted its stake in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares during the period. Sharkey Howes & Javer boosted its stake in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares during the period. CWM LLC boosted its stake in Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after buying an additional 103 shares during the period. Finally, FNY Managed Accounts LLC acquired a new stake in Thermo Fisher Scientific during the first quarter worth approximately $153,000. Institutional investors and hedge funds own 87.15% of the company’s stock.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 173.26 on Thursday. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $182.87. The firm’s 50-day moving average price is $176.96 and its 200-day moving average price is $165.20. The firm has a market cap of $67.57 billion, a price-to-earnings ratio of 30.18 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.03 earnings per share. On average, equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc (NYSE:TMO) Stake Maintained by Spirit of America Management Corp NY” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://sportsperspectives.com/2017/08/10/thermo-fisher-scientific-inc-nysetmo-stake-held-by-spirit-of-america-management-corp-ny-updated-updated.html.

A number of analysts have recently commented on the company. Bank of America Corporation boosted their price objective on Thermo Fisher Scientific from $190.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, May 9th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Jefferies Group LLC boosted their price objective on Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a research report on Friday, April 28th. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 27th. Finally, Citigroup Inc. reaffirmed a “buy” rating and issued a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a research note on Monday, July 10th. One investment analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $188.56.

In other news, insider Daniel P. Shine sold 4,688 shares of the firm’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total transaction of $805,773.44. Following the sale, the insider now owns 29,200 shares in the company, valued at $5,018,896. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $172.79, for a total value of $3,455,800.00. Following the sale, the chief executive officer now owns 269,279 shares in the company, valued at approximately $46,528,718.41. The disclosure for this sale can be found here. Insiders have sold 27,188 shares of company stock worth $4,702,223 in the last 90 days. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply